KATZ NANCY E 4
4 · NeuroMetrix, Inc. · Filed May 2, 2024
Insider Transaction Report
Form 4
KATZ NANCY E
Director
Transactions
- Exercise/Conversion
Common Stock
2024-04-30$4.37/sh+5,396$23,581→ 7,602 total - Exercise/Conversion
Restricted Stock Unit
2024-04-30$4.37/sh−5,396$23,581→ 0 totalExercise: $4.37From: 2024-04-30Exp: 2024-04-30→ Common Stock (5,396 underlying)
Footnotes (2)
- [F1]Represents shares earned upon the vesting of restricted stock units referred to in footnote 2.
- [F2]On August 4, 2023, the reporting person was granted 43,165 restricted stock units prior to the reverse stock split of the Issuer's common stock at a ratio 1-for-8, effective as of November 21, 2023, which vested 100% on April 30, 2024.